Skip to content
10-K

Annual Report

PERSPECTIVE THERAPEUTICS, INC. CATX

0000728387-26-000004

← back to feed
Filed
Mar 16, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 12, 2026 113.93M sh
Shares Diluted FY 2025 · Dec 31, 2025 73.81M sh
Capex FY 2025 · Dec 31, 2025 $12.75M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$82.48M
Long Term Debt FY 2025 · Dec 31, 2025 $1.63M
Short Term Investments FY 2025 · Dec 31, 2025 $114.11M
Cash And Equivalents FY 2025 · Dec 31, 2025 $30.63M
Stockholders Equity FY 2025 · Dec 31, 2025 $207.03M
Current Liabilities FY 2025 · Dec 31, 2025 $28.68M
Total Liabilities FY 2025 · Dec 31, 2025 $59.94M
Current Assets FY 2025 · Dec 31, 2025 $148.39M
Total Assets FY 2025 · Dec 31, 2025 $266.97M
Eps Diluted FY 2025 · Dec 31, 2025 −$1.40
Eps Basic FY 2025 · Dec 31, 2025 −$1.40
Sga Expense FY 2025 · Dec 31, 2025 $30.23M
Rd Expense FY 2025 · Dec 31, 2025 $84.22M
Net Income FY 2025 · Dec 31, 2025 −$103.12M
Operating Income FY 2025 · Dec 31, 2025 −$113.56M
Stock Issued FY 2025 · Feb 18, 2025 3.38M sh